Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yield10 Bioscience's earnings per share without non-recurring items for the
three
months ended in Jun. 2024 was $-5.04.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was $-26.13.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Yield10 Bioscience's EPS without NRI or its related term are showing as below:
YTENQ's 3-Year EPS without NRI Growth Rate is not ranked *
in the Agriculture industry.
Industry Median: -4.4 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Yield10 Bioscience's EPS (Basic) for the
three
months ended in Jun. 2024 was $-5.04.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $-26.13.
Yield10 Bioscience (OTCPK:YTENQ) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Yield10 Bioscience EPS without NRI Related Terms
Yield10 Bioscience EPS without NRI Historical Data
* Premium members only.
The historical data trend for Yield10 Bioscience's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YTENQ vs GNVR, CTVA, CF: EPS without NRI Comparison
For the Agricultural Inputs subindustry, Yield10 Bioscience's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yield10 Bioscience PE Ratio without NRI vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Yield10 Bioscience's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Yield10 Bioscience's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yield10 Bioscience (YTENQ) has a EPS without NRI of $-26.13 as of Jun. 2024. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Yield10 Bioscience and its competitors.
Is Yield10 Bioscience's EPS without NRI too high?
Yield10 Bioscience's current EPS without NRI is $-26.13. Overall, Yield10 Bioscience has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Yield10 Bioscience's EPS without NRI compare to GNVR and CTVA?
Yield10 Bioscience's EPS without NRI of $-26.13 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Agriculture company?
A good EPS without NRI depends on the Agriculture industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Yield10 Bioscience and its competitors. Yield10 Bioscience's current EPS without NRI is $-26.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yield10 Bioscience stock overvalued right now?
Yield10 Bioscience (YTENQ) has a current EPS without NRI of $-26.13. The current EPS without NRI is $-26.13. Yield10 Bioscience's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Yield10 Bioscience (YTENQ), the current EPS without NRI is $-26.13 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yield10 Bioscience Inc is an agricultural bioscience company. It is leveraging advanced genetics to develop the oilseed Camelina sativa as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA bioplastics for use as biodegradable bioplastics.
16GF Score
Get the complete analysis for YTENQ
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YTENQ has been successfully added to your 
